skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial

Review

(2161) Views  (798) Full article downloads

Authors: Lorenzo Aguilar, María-José Giménez, José Barberán

Published Date June 2010 Volume 2010:3 Pages 35 - 43
DOI: http://dx.doi.org/10.2147/IDR.S8964

Lorenzo Aguilar1, María-José Giménez1, José Barberán2

1Microbiology Department, School of Medicine, University Complutense, Madrid; 2Infectious Diseases Department, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain

Abstract: The nasopharynx is the ecological niche where evolution towards resistance occurs in respiratory tract isolates. Dynamics of different bacterial populations in antibiotic-free multibacterial niches are the baseline that antibiotic treatments can alter by shifting the competitive balance in favor of resistant populations. For this reason, antibiotic resistance is increasingly being considered to be an ecological problem. Traditionally, resistance has implied the need for development of new antibiotics for which basic efficacy and safety data are required prior to licensing. Antibiotic development is mainly focused on demonstrating clinical efficacy and setting susceptibility breakpoints for efficacy prediction. However, additional information on pharmacodynamic data predicting absence of selection of resistance and of resistant subpopulations, and specific surveillance on resistance to core antibiotics (to detect emerging resistances and its link with antibiotic consumption in the community) are valuable data in defining the role of a new antibiotic, not only from the perspective of its therapeutic potential but also from the ecologic perspective (countering resistances to core antibiotics in the community). The documented information on cefditoren gleaned from published studies in recent years is an example of the role for an emerging oral antibacterial facing current antibiotic resistance in community-acquired respiratory tract infections.

Keywords: respiratory tract infection, antibiotic resistance, cefditoren, community






 

Other articles by Dr Lorenzo Aguilar



Readers of this article also read:

Current and novel antibiotics against resistant Gram-positive bacteria
The determinants of the antibiotic resistance process
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Lyme disease: the next decade
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Effect of long-term treatment with eyedrops for glaucoma on conjunctival bacterial flora
Resistance to antimicrobial drugs in Ghana
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University